These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28911947)

  • 1. Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial.
    China L; Skene SS; Shabir Z; Maini A; Sylvestre Y; Bennett K; Bevan S; O'Beirne J; Forrest E; Portal J; Ryder S; Wright G; Gilroy DW; O'Brien A
    Clin Gastroenterol Hepatol; 2018 May; 16(5):748-755.e6. PubMed ID: 28911947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease.
    China L; Maini A; Skene SS; Shabir Z; Sylvestre Y; Colas RA; Ly L; Becares Salles N; Belloti V; Dalli J; Gilroy DW; O'Brien A
    Clin Gastroenterol Hepatol; 2018 May; 16(5):738-747.e7. PubMed ID: 28859868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial.
    China L; Skene SS; Bennett K; Shabir Z; Hamilton R; Bevan S; Chandler T; Maini AA; Becares N; Gilroy D; Forrest EH; O'Brien A
    BMJ Open; 2018 Oct; 8(10):e023754. PubMed ID: 30344180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.
    China L; Muirhead N; Skene SS; Shabir Z; De Maeyer RP; Maini A; Gilroy DW; O'Brien AJ
    BMJ Open; 2016 Jan; 6(1):e010132. PubMed ID: 26810999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
    China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; Portal AJ; Becares Salles N; Gilroy DW; O'Brien A;
    N Engl J Med; 2021 Mar; 384(9):808-817. PubMed ID: 33657293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
    Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
    Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.
    Piano S; Schmidt HH; Ariza X; Amoros A; Romano A; Hüsing-Kabar A; Solà E; Gerbes A; Bernardi M; Alessandria C; Scheiner B; Tonon M; Maschmeier M; Solè C; Trebicka J; Gustot T; Nevens F; Arroyo V; Gines P; Angeli P;
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1792-1800.e3. PubMed ID: 29391267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failure.
    Fernández J; Lozano M; Torres M; Horrillo R; Afonso N; Núñez L; Mestre A; Pérez A; Cid J; Costa M; Arroyo V; Páez A
    JHEP Rep; 2024 Apr; 6(4):101017. PubMed ID: 38544553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation.
    Nevens F; Gustot T; Laterre PF; Lasser LL; Haralampiev LE; Vargas V; Lyubomirova D; Albillos A; Najimi M; Michel S; Stoykov I; Gordillo N; Vainilovich Y; Barthel V; Clerget-Chossat N; Sokal EM
    JHEP Rep; 2021 Aug; 3(4):100291. PubMed ID: 34169246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.